COVID-19 and the future of vaccines
Go Deeper.
Create an account or log in to save stories.
Like this?
Thanks for liking this story! We have added it to a list of your favorite stories.
The race is on to find a viable vaccine for COVID-19. Several are already in a trial phase. One was designed within three hours of the company getting the novel coronavirus’ genetic code.
These events take place in a new world of vaccine research and development. What used to take two or three years now takes weeks. Vaccines are being customized for individuals, incorporating their personal DNA. Therapeutic cancer vaccines can attack tumors from within. It’s an exciting and interesting branch of science. Monday, we spoke with two preeminent vaccine researchers about nontraditional and innovative approaches to vaccines.
Guests:
Dr. Greg Poland, vaccine researcher and infectious disease specialist with Mayo Clinic
Dr. Nora Disis, professor of medicine at the University of Washington’s Cancer Vaccine Institute
To listen to the full conversation you can use the audio player above.
Subscribe to the MPR News with Kerri Miller podcast on: Apple Podcasts, Google Podcasts , Spotify or RSS
Turn Up Your Support
MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all.
